December 29, 2014 1:04 AM ET

Healthcare Providers and Services

Company Overview of InVitae Corporation

Company Overview

InVitae Corporation, a genetic information company, provides genetic diagnostics for various hereditary disorders. The company provides gene sequencing and deletion/duplication analysis for disorders in various medical specialties that include cardiology, such as long and short QT syndrome, Brugada syndrome, and hypertrophic cardiomyopathy; hereditary cancers, including breast, ovarian, and endometrial cancers, as well as colon and pancreatic cancers; pediatric genetics; neurology; and hematology. It also offers tools, such as Family History Tool that enables users to digitally build, modify, share, and save patient pedigrees, as well as assess their risks and decide on the appropriate genet...

458 Brannan Street

San Francisco, CA 94107

United States

Founded in 2012





Key Executives for InVitae Corporation

Member of Strategy Team
Member of Strategy Team
Age: 56
Member of Strategy Team
Member of Strategy Team
Member of Strategy Team
Compensation as of Fiscal Year 2014.

InVitae Corporation Key Developments

Invitae Corporation and Nanopharmacia Announce Partnership to Make Reliable, Fast and Affordable Hereditary Cancer Genetic Testing Broadly Available in Mexico

Invitae Corporation and Nanopharmacia announced an exclusive partnership to make Invitae's genetic tests for the management of hereditary cancers broadly available throughout Mexico. In addition, the partnership includes access on a non-exclusive basis in Costa Rica and Panama. Nanopharmacia will offer Invitae's hereditary cancer panels and BRCA1/BRCA2 offering to a wide network of onco-geneticists and medical and surgical oncologists. Invitae's oncology offering includes: Single gene BRCA1 and BRCA2, including full gene sequencing and deletion/duplication analysis; High-risk hereditary breast cancer panel (6 genes); Women's hereditary cancer panel (18 genes associated with hereditary breast, ovarian and endometrial cancer); Hereditary cancer syndromes panel (29 genes); Hereditary Pancreatic Cancer Panel (17 genes); Additional hereditary cancer panels are available, including testing for Lynch Syndrome and colon cancers. The partnership includes access for advanced next generation genetic testing in Mexico through a network of approximately 800 oncology professionals in Mexico, as well as in Costa Rica and Panama.

InVitae Corporation Offers Multi-Gene Testing for Hereditary Pancreatic Cancer

Invitae Corporation announced that it now offers multi-gene testing for hereditary pancreatic cancer, providing clinicians with a reliable, fast and affordable option for their cancer patients and their families. With results typically available within three weeks, this panel includes an analysis of 17 genes and currently is the most comprehensive panel available. The test is available globally and at a contracted price of $1,500 in the United States. The new Invitae Hereditary Pancreatic Cancer Panel covers the genetic associations most commonly linked to an increased risk of pancreatic cancer and includes the following genes: APC, ATM, BRCA1, BRCA2, CDKN2A, EPCAM, FANCC, MEN1, MLH1, MSH2, MSH6, PALB2, PALLD, PMS2, STK11, TP53 and VHL. In addition, Invitae offers hereditary pancreatitis genes CFTR and SPINK1, which some providers choose when assessing a patient for hereditary pancreatic cancer. These genes can be included in an Invitae requisition at no additional charge. Additional hereditary cancer panels are available, including testing for BRCA1 and BRCA2, Lynch Syndrome and other colon cancers, and a 29-gene hereditary cancer syndromes panel. In addition to covering more genes than tests available from other providers, Invitae's newest cancer panel provides clinicians and patients with answers more rapidly, at a lower cost.

InVitae Corporation Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 05:00 PM

InVitae Corporation Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-14-2014 05:00 PM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Sean George PhD, President.

Similar Private Companies By Industry

Company Name Region
Surgery Center of Tempe, L.L.C. United States
University of Mississippi Medical Center Grenada United States
The Oaks United States
Western New York Dental Group PC United States
CAP Medical Group, PLLC United States

Recent Private Companies Transactions

Private Placement
October 13, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InVitae Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at